Meta tags:
description= For over 35 years Parexel has been a trusted global CRO and biopharmaceutical services company. Learn more about how we can help.;
keywords= biopharmaceutical services;
Headings (most frequently used words):
and, she, in, her, to, patients, trials, the, was, we, clinical, tina, for, can, inflammation, on, like, immunology, ever, our, faster, agility, who, precision, care, specialists, collaborate, change, with, design, you, when, lives, of, needs, focused, keep, get, because, your, therapeutic, quick, websites, regional, resources, about, sites, participate, report, latest, insights, expertise, solutions, treatment, more, difference, make, so, than, better, deliver, us, inspire, they, experiences, focus, help, has, sharing, proudly, city, york, new, lived, 20s, early, organizations, research, largest, world, among, is, promising, parexel, diagnosis, own, faced, now, disease, crohn, father, lost, had, are, building, future, advocate, worked, patient, today, since, been, remission, months, within, trial, enrolled, finally, then, nothing, herself, surgeries, 20, underwent, medications, countless, trying, years, 10, next, spent, finance, links,
Text of the page (most frequently used words):
and (68), the (33), #clinical (26), for (23), #development (22), #patient (21), strategy (18), our (17), #trials (14), #patients (13), #trial (13), #medical (13), #with (11), more (10), close (10), expertise (10), solutions (10), access (9), global (9), #insights (9), regulatory (9), drug (9), world (8), your (8), she (8), #therapeutic (8), sites (7), her (7), disease (7), menu (7), learn (7), inflammation (7), what (7), market (7), immunology (7), management (7), new (6), research (6), parexel (6), about (6), compliance (6), privacy (6), are (6), this (6), annual (6), you (5), delivery (5), phase (5), services (5), optimization (5), advocate (5), help (5), meeting (5), gene (5), cell (5), participate (5), team (5), experts (5), site (5), data (4), tina (4), portfolio (4), engagement (4), not (4), medicines (4), diagnosis (4), evidence (4), advice (4), can (4), communications (4), provided (4), content (4), early (4), include (4), real (4), those (4), any (4), only (4), 2024 (4), end (4), including (4), material (4), see (4), care (4), careers (4), make (4), therapies (4), from (4), may (3), excellence (3), how (3), under (3), participating (3), benefits (3), summit (3), lives (3), operational (3), experience (3), across (3), through (3), that (3), find (3), guidance (3), protocol (3), get (3), oncology (3), medicine (3), was (3), reach (3), use (3), tax (3), has (3), rare (3), treatment (3), change (3), international (3), lifecycle (3), meet (3), terms (3), event (3), newsroom (3), academy (3), like (3), contact (3), integrated (3), valuation (3), policy (3), who (3), design (3), planning (3), perspectives (3), asset (3), inclusion (2), therapy (2), neuroscience (2), john (2), chapter (2), michael (2), diseases (2), experiences (2), collaborate (2), considered (2), changing (2), innovative (2), modern (2), congress (2), slavery (2), statement (2), vaccine (2), accelerating (2), designs (2), enrollment (2), allow (2), keep (2), act (2), utilize (2), innovation (2), america (2), than (2), life (2), indications (2), diversity (2), andreas (2), building (2), volunteers (2), supplier (2), conditions (2), executive (2), one (2), crohn (2), had (2), pay (2), vice (2), president (2), solicitation (2), needs (2), out (2), story (2), many (2), leveraging (2), gender (2), cro (2), there (2), esg (2), years (2), fda (2), trying (2), answers (2), guided (2), achieving (2), novel (2), director (2), then (2), final (2), decisions (2), assessment (2), these (2), factors (2), helps (2), informed (2), offers (2), ever (2), careful (2), graphics (2), investigational (2), images (2), text (2), disclaimer (2), opinions (2), informational (2), potential (2), commitment (2), does (2), while (2), such (2), better (2), cutting (2), edge (2), treatments (2), expert (2), contributing (2), time (2), however (2), risks (2), today (2), side (2), effects (2), unpredictable (2), outcomes (2), purposes (2), expressed (2), faster (2), approval (2), advertisement (2), models (2), want (2), latest (2), supply (2), biotech (2), logistics (2), explore (2), deliver (2), areas (2), fsp (2), promotion (2), all (2), should (2), drugs (2), constitute (2), professional (2), largest (2), please (2), represent (2), consult (2), value (2), healthcare (2), their (2), outsourcing (2), consent (2), substantiation (2), distribution (2), submissions (2), interested (2), biopharmaceutical (2), french, based, requirements, ethics, review, sheri, eric, susan, salka, groetelaars, bruun, maykin, bill, liu, chase, case, dpf, asgct, adaptive, edi, conference, iscr, 17th, aan, dermatology, profile, claims, throughout, orphan, ispor, airis, ats, aacr, strategies, assets, framework, performance, indication, partners, americas, maps, ascpt, acrp, drives, every, prioritization, into, rbqm, establishing, complexity, managing, step, mccoy, frequently, jonathan, navigator, stay, advancing, discussions, overview, gap, bridging, binary, beyond, revision, industry, q5a, ich, exploring, draft, products, cgt, assurance, potency, iib, forefront, ahead, car, convention, digital, safety, pharmacovigilance, risk, fso, technology, driven, customized, solution, pediatrics, advantage, gain, passion, leading, combining, general, vaccines, infectious, cross, product, report, shough, speeding, offer, concept, studies, heart, believe, engaging, iia, cros, welcome, model, macdonald, jamie, howell, peyton, rush, greg, bell, crowley, would, opportunity, questions, hear, asked, process, joining, thinking, healthy, groups, biomarker, advocacy, genomic, alliance, discuss, stories, network, baltimore, angeles, los, london, kol, proof, berlin, 2023, glob, bio, execution, south, europe, apac, africa, east, middle, impact, maximum, optimize, relevant, around, deeper, results, approach, first, tactics, capabilities, visit, someone, speak, ready, north, accelerate, difference, struggles, drawing, challenges, its, old, boundaries, push, waiting, remind, went, match, study, strong, 100, efficient, fast, result, recruitment, project, diverse, startups, touch, investigator, 919, websites, regional, japan, china, links, quick, 3170, 544, 27713, durham, parkway, meridian, 2520, service, reserved, rights, corporation, invoicing, communication, inspire, anywhere, they, because, focus, organizations, among, proudly, range, full, leaders, mind, anyone, preferences, option, partnership, works, professionals, 000, breadth, providing, dedicated, resources, clinician, thought, dia, finding, surprise, wasn, worldwide, people, million, affect, syndromes, ibd, two, came, family, finance, herself, future, promising, city, york, lived, 20s, worked, nothing, considering, history, society, asco, ctr, transition, countdown, scrs, differences, similarities, sclerosis, multiple, alzheimer, but, search, home, scroll, click, own, faced, now, father, lost, derailed, surgeries, underwent, leader, section, seamless, specialists, farahat, ayman, arya, bharti, vaneenwyk, claire, pietzak, michelle, reiff, participants, head, senior, analyses, complex, assists, also, projects, scientific, strategic, provides, support, chronic, medications, focused, countless, next, spent, enrolled, finally, since, been, remission, months, within, sharing, feel, precision, agility, when, demands, urgent, deep, right, cared, safe, main,
Text of the page (random words):
cro biopharmaceutical services parexel solutions therapeutic expertise insights participate sites about newsroom academy careers 中国 日本 contact us main menu newsroom academy careers 中国 日本 contact us solutions therapeutic expertise insights participate sites about close menu solutions explore end to end solutions throughout development from portfolio optimization and regulatory strategy to phase i iv clinical trials market access planning and more see solutions what we do portfolio management and asset valuation early development and innovation integrated clinical development approval and access value substantiation lifecycle management how we do it operational excellence biotech delivery models portfolio management and asset valuation building patient insights into assets profile and claims portfolio optimization asset valuation and indication prioritization early evidence review model based drug development integrated development strategy and planning early development and innovation phase i clinical trials proof of concept studies phase ib iia patient engagement strategy and enrollment solutions patient inclusion site alliance network and kol engagement protocol optimization regulatory strategy market access strategy and delivery biomarker and genomic medicine strategy clinical trial supply logistics medical communications integrated clinical development phase iib iv clinical trials real world evidence patient engagement strategy and enrollment solutions patient inclusion protocol driven customized site solution strategy regulatory strategy submissions compliance and outsourcing market access strategy and delivery clinical development technology optimization clinical trial supply logistics medical communications approval and access real world evidence global regulatory submissions and outsourcing compliance and risk management market access strategy and delivery medical communications value substantiation lifecycle management real world evidence market access strategy and planning regulatory compliance drug safety and pharmacovigilance lifecycle optimization medical communications operational excellence leveraging ai and digital in clinical development biotech clinical trial solutions delivery models from fsp to fso gain an advantage through fsp close menu therapeutic expertise utilize our expertise across therapeutic areas combining innovative trial designs leading clinical and regulatory expertise global reach and a passion for changing patient lives see expertise therapeutic expertise neuroscience general medicine infectious disease vaccines inflammation immunology oncology cross therapeutic expertise cell gene therapies pediatrics rare diseases close menu insights our experts help you stay at the forefront of the industry and ahead of change see insights new medicines novel insights advancing rare disease drug development accelerating development of cell and gene therapies achieving patient guided drug development discussions on diversity overview chapter 1 bridging the gap chapter 2 beyond the binary the regulatory navigator exploring ich q5a revision 2 potency assurance for cgt products fda s new draft guidance the fda s final guidance car t product development latest report new medicines novel insights achieving patient guided drug development learn more close menu participate thinking about joining a clinical trial learn the drug development process what it s like to participate how to find a trial and answers to frequently asked questions learn more interested in participating healthy volunteers patient volunteers patient advocacy groups hear from real patients patient stories trial sites baltimore los angeles london berlin close menu sites want to collaborate with us to offer clinical trials at your site we would welcome the opportunity to discuss learn more close menu about we are one of the largest cros in the world speeding life changing medicine to market by engaging patients with heart learn about who we are what we do and what we believe about parexel management team global reach our de i strategy our esg strategy compliance tax privacy meet us at an event management team jamie macdonald peyton howell greg rush john bell michael crowley jonathan shough sheri mccoy eric liu bill chase maykin ho michael bruun john groetelaars susan salka global reach our de i strategy our esg strategy compliance tax privacy compliance ethics tax strategy privacy policy supplier data privacy requirements terms of use french gender pay data uk gender pay data uk modern slavery act statement eu u s data privacy framework eu u s dpf supplier diversity policy meet us at an event world vaccine congress patients as partners u s maps americas ascpt 2024 annual meeting acrp 2024 managing complexity in cell and gene trials establishing an rbqm strategy that drives better performance edi in clinical research the case for adaptive strategies at every step 17th iscr annual conference 2024 include site solutions summit aan annual meeting asgct annual meeting dermatology drug development summit eu world orphan drug congress us ispor us airis ats 2024 aacr annual meeting bio international convention dia global annual meeting international society for cell gene therapy asco final countdown how to transition your trials under eu ctr scrs oncology site solutions summit accelerating vaccine development through operational excellence alzheimer s disease vs multiple sclerosis drug development similarities differences new perspectives close search what can we help you find today home click or scroll the perspectives and opinions expressed in this material represent those of the patient advocate only and should not be considered a solicitation promotion or advertisement for any services of parexel or any drugs or therapies including those under development participating in clinical trials for investigational medicines offers patients potential benefits such as access to cutting edge treatments and expert medical care while contributing to medical research however risks may include side effects unpredictable outcomes and time commitment careful assessment of these factors helps patients make informed decisions the content of this material including graphics images and text is provided for informational purposes only and does not constitute medical advice diagnosis or treatment please consult your healthcare professional for medical advice the patient advocate has provided their consent for the use and distribution of this content close patient story inflammation immunology oncology rare diseases cell gene therapy neuroscience tina had lost her father to crohn s disease now she faced her own diagnosis disclaimer then came the diagnosis finding out she had crohn s disease one of two ibd syndromes that affect 10 million people worldwide wasn t a surprise considering her family s history with the disease but it derailed her life tina was in her early 20s she lived in new york city and was building a promising future for herself in finance she spent the next 10 years trying countless medications and underwent 20 surgeries nothing worked then finally she enrolled in a clinical trial within months she was in remission and has been ever since today she s a patient advocate sharing her experiences to help keep our clinical trials focused on the needs of patients like her lives can change when you design inflammation and immunology trials with agility precision and care keep up with urgent clinical demands utilize the right experts with deep i i experience help participants with chronic conditions feel safe and cared for get seamless end to end support across indications what we do we do our experts our inflammation and immunology specialists collaborate to get your treatment to patients faster more experts ayman farahat vice president glob bharti arya executive director claire vaneenwyk m d executive director michelle pietzak m d global ta section he close our experts andreas reiff m d senior vice president global ta head inflammation immunology global medical services drawing from 25 years of experience as a clinician investigator and thought leader andreas provides strategic regulatory and scientific guidance for your projects in inflammation and immunology he also assists with protocol development and complex market analyses tina s story and the many struggles she went through remind us that there are many patients out there who are waiting for us to push the boundaries of research trying to find new answers to an old disease and its challenges our i i team is 13 100 strong with experience across indications to match the needs of your trial our diverse project experiences and expertise in patient recruitment and engagement result in fast efficient trials clinical trial sites around the world allow us to accelerate study startups north america south america europe apac middle east africa innovative trial designs allow us to optimize your trials for maximum impact and our patient first approach results in deeper more relevant insights for trial design and execution tactics benefits may include what can we do to help you change patient lives see i i capabilities visit all therapeutic areas explore i i careers want our latest insights for inflammation and immunology learn more ready to speak to someone on our team get in touch are you a patient interested in a clinical trial learn more the perspectives and opinions expressed in this material represent those of the patient advocate only and should not be considered a solicitation promotion or advertisement for any services of parexel or any drugs or therapies including those under development participating in clinical trials for investigational medicines offers patients potential benefits such as access to cutting edge treatments and expert medical care while contributing to medical research however risks may include side effects unpredictable outcomes and time commitment careful assessment of these factors helps patients make informed decisions the content of this material including graphics images and text is provided for informational purposes only and does not constitute medical advice diagnosis or treatment please consult your healthcare professional for medical advice the patient advocate has provided their consent for the use and distribution of this content close we focus on patients because they inspire us to deliver better trials faster than ever so we can make a difference for more patients like tina disclaimer who we are parexel is proudly among the world s largest clinical research organizations a dedicated cro providing the full range of phase i to iv clinical development services and leveraging the breadth of our clinical regulatory and therapeutic expertise our team of more than 21 000 global professionals works in partnership with biopharmaceutical leaders and sites to design and deliver clinical trials with patients in mind to make clinical research a care option for anyone anywhere contact us meet us at an event resources my communication preferences invoicing po terms and conditions regional websites japan china quick links participate sites careers newsroom academy 2520 meridian parkway durham nc 27713 1 919 544 3170 privacy policy terms of service modern slavery statement act 2023 parexel international ma corporation all rights reserved
|